ClinConnect ClinConnect Logo
Search / Trial NCT04903535

External Nitric Oxide Measurement Through SNO Degradation

Launched by INDIANA UNIVERSITY · May 25, 2021

Trial Information

Current as of August 20, 2025

Enrolling by invitation

Keywords

ClinConnect Summary

S-nitrosylation is the covalent attachment of a nitric oxide group to cystine thiol within a protein to form an S-nitrosothiol (SNO); it has diverse regulatory roles in all mammalian cells and thus operates as a fundamental mechanism for cellular signaling and accounts for a large part of nitric oxide activity. Though SNOs are relevant to many biological disciplines like neuronal, muscular, respiratory, and cardiovascular biology, currently there is no way to measure SNOs that is both easy to use in a clinical setting and accurate in detecting low concentrations; detection is challenging du...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria
  • Adult males or females age ≥ 1 day and ≤ 75 years at time of enrollment
  • Exclusion Criteria
  • * Subjects meeting the following criteria will be excluded:
  • Smokers.
  • Any chronic skin conditions.
  • Pregnant.
  • Subjects that are unable or unwilling to cooperate with specimen collection.
  • Subjects with diagnosis of any medical condition that in the investigator's opinion would make them unsuitable for study participation.
  • (for subjects ≥ 18) Subjects that lack the capacity to consent for themselves.

About Indiana University

Indiana University, a leading research institution, is committed to advancing healthcare through innovative clinical trials and rigorous scientific inquiry. With a focus on improving patient outcomes, the university conducts a wide range of studies across various medical disciplines, leveraging its extensive resources and collaborative networks. Indiana University's dedication to ethical research practices and community engagement ensures that its clinical trials not only contribute to scientific knowledge but also prioritize participant safety and well-being. Through its commitment to excellence, Indiana University plays a pivotal role in shaping the future of medicine and enhancing public health.

Locations

Indianapolis, Indiana, United States

Indianapolis, Indiana, United States

Patients applied

0 patients applied

Trial Officials

Nadzeya Marozkina, PhD, MD

Principal Investigator

Indiana University School of Medicine

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials